Cargando…
Certolizumab in the long-term treatment of rheumatoid arthritis
Rheumatoid arthritis is the most common inflammatory arthritis and continues to have major long-term effects on quality of life. Early and intensive treatment has now become the norm in clinical practice with changes of medication dictated by measuring the presence of continued disease activity. Bio...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074781/ https://www.ncbi.nlm.nih.gov/pubmed/27790005 http://dx.doi.org/10.2147/OARRR.S14556 |